Evidence map›Paper›PMID 31101849›Full record

ArticleScientific reports2019

CRISPR/Cas9-mediated ablation of elovl2 in Atlantic salmon (Salmo salar L.) inhibits elongation of polyunsaturated fatty acids and induces Srebp-1 and target genes.

Alex K Datsomor, Nikola Zic, Keshuai Li, Rolf E Olsen, Yang Jin, Jon Olav Vik, Rolf B Edvardsen, Fabian Grammes, Anna Wargelius, Per Winge

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Towards Sustainable Aquafeeds: Microalgal (Foods (Basel, Switzerland) · 2025
    Article
  7. Generation of IgMScientific reports · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Contribution ofAnimals : an open access journal from MDPI · 2024
    Article
  15. 3 Biotech · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Alex K DatsomorNorwegian University of Science and Technology, Department of Biology, Trondheim, N-7491, Norway.
Nikola ZicNorwegian University of Science and Technology, Department of Biology, Trondheim, N-7491, Norway.
Keshuai LiNorwegian University of Science and Technology, Department of Biology, Trondheim, N-7491, Norway.
Rolf E OlsenNorwegian University of Science and Technology, Department of Biology, Trondheim, N-7491, Norway.
Yang JinNorwegian University of Life Sciences, Department of Animal and Aquacultural Sciences, N-1432, Ås, Norway.
Jon Olav VikNorwegian University of Life Sciences, Department of Animal and Aquacultural Sciences, N-1432, Ås, Norway.
Rolf B EdvardsenInstitute of Marine Research, Bergen, N-5817, Norway.
Fabian GrammesNorwegian University of Life Sciences, Department of Animal and Aquacultural Sciences, N-1432, Ås, Norway.
Anna WargeliusInstitute of Marine Research, Bergen, N-5817, Norway. anna.wargelius@hi.no.
Per WingeNorwegian University of Science and Technology, Department of Biology, Trondheim, N-7491, Norway. per.winge@ntnu.no.
Norwegian University of Science and Technology · NONorwegian University of Life Sciences · NONorwegian Institute of Marine Research · NOBioMar (Norway) · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atlantic salmon can synthesize polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid (20:5n-3), arachidonic acid (20:4n-6) and docosahexaenoic acid (22:6n-3) via activities of very long chain fatty acyl elongases (Elovls) and fatty acyl desaturases (Fads), albeit to a limited degree. Understanding molecular mechanisms of PUFA biosynthesis and regulation is a pre-requisite for sustainable use of vegetable oils in aquafeeds as current sources of fish oils are unable to meet increasing demands for omega-3 PUFAs. By generating CRISPR-mediated elovl2 partial knockout (KO), we have shown that elovl2 is crucial for multi-tissue synthesis of 22:6n-3 in vivo and that endogenously synthesized PUFAs are important for transcriptional regulation of lipogenic genes in Atlantic salmon. The elovl2-KOs showed reduced levels of 22:6n-3 and accumulation of 20:5n-3 and docosapentaenoic acid (22:5n-3) in the liver, brain and white muscle, suggesting inhibition of elongation. Additionally, elovl2-KO salmon showed accumulation of 20:4n-6 in brain and white muscle. The impaired synthesis of 22:6n-3 induced hepatic expression of sterol regulatory element binding protein-1 (srebp-1), fatty acid synthase-b, Δ6fad-a, Δ5fad and elovl5. Our study demonstrates key roles of elovl2 at two penultimate steps of PUFA synthesis in vivo and suggests Srebp-1 as a main regulator of endogenous PUFA synthesis in Atlantic salmon.

Indexed as

AnimalsArachidonic AcidBrainCRISPR-Cas SystemsDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acid ElongasesFatty Acids, Omega-3Fatty Acids, UnsaturatedFatty Acid SynthasesGene Knockout TechniquesLipid MetabolismMusclesSalmo salarSterol Regulatory Element Binding Protein 1Arachidonic AcidDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acid ElongasesFatty Acids, Omega-3Fatty Acids, UnsaturatedFatty Acid SynthasesSterol Regulatory Element Binding Protein 1

Identifiers

PMID31101849
PMCPMC6525179
OpenAlexW2945949228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.